Pune, India -- (SBWIRE) -- 05/08/2019 -- Continuous Blood Glucose Monitoring Systems Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of continuous blood glucose monitoring systems market by component (CGM monitor, CGM transmitter, and glucose sensor) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the continuous blood glucose monitoring systems market it includes the five years industry analysis and the 6 years annual forecast from 2019 to 2025. According to the report, the global continuous blood glucose monitoring systems market is projected to grow at a CAGR of 23.1% over the forecast period of 2019-2025.

Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/5961

Continuous Blood Glucose Monitoring Systems Market: Insights

During the last four decades, there have been continuous advances in the field of glucose monitoring, which have led to the development of highly evolved blood glucose meters, including non-invasive glucose monitoring (NGM) devices and continuous blood glucose monitoring systems (CGM). Glucose monitoring is an integral part of diabetes management and the maintenance of physiological blood glucose concentration is the only way for a diabetic to avoid life-threatening diabetic complications. CGM systems have led to tremendous improvements in diabetic management, as shown by the significant lowering of glycated hemoglobin (HbA1c) in adults with type I diabetes. Most of the CGMS has been minimally-invasive, although the more recent ones are based on NGM techniques

Continuous Blood Glucose Monitoring Systems Market: Drivers and Restraints

Diabetes disease is growing across the globe at an extraordinary pace and has become a serious health issue during the last two decades. It is a major cause of mortality in the age group of 20–79 years. Based on its rapidly increasing incidence, it has been declared a global epidemic by the World Health Organization (WHO). According to the International Diabetes Federation (IDF), the number of diabetic patients reached 415 million in 2015 globally and is expected to reach around 642 million by 2040. According to the IDF, global healthcare expenditures to treat diabetes and its complications were USD 673 billion in 2015, representing 12% of total global healthcare expenditures and is expected to exceed USD 802 billion by 2040. Rise in base of geriatric population, increasing incidence rates of diabetes worldwide, benefits of CBGM devices over blood glucometers such as reports generation and access for historic blood glucose data to analyze the trend, growing awareness among the population, increasing preference for non-invasive methods, and approval of artificial pancreas from FDI is expected to drive the market at a significant growth rate in the coming years. However, stringent regulatory approvals and high costs associated with these devices are some of the restraining factors which could hinder the market.

Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/5961

Continuous Blood Glucose Monitoring Systems Market: Regional Analysis

Among the geographies, North America holds the maximum market share of continuous blood glucose monitoring systems (CGM) market followed by Europe. The rapidly growing prevalence of diabetes and growing awareness about the prevention of diabetes is the key factors that drive the growth of North America continuous glucose monitoring system market. Additionally, favorable government and developed healthcare infrastructures are majorly contributing to the growth of this market in the North America region. Moreover, Asia Pacific is the fastest growing region in the glucose monitoring systems (CGM) market owing to the growing prevalence of diabetes, rapidly changing lifestyles, growing geriatric population

Continuous Blood Glucose Monitoring Systems Market: Segmentation

The report on global continuous blood glucose monitoring systems market covers segments such as component. On the basis of component, the sub-markets include CGM monitor, CGM transmitter, and glucose sensor.

Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-continuous-blood-glucose-monitoring-systems-market

Continuous Blood Glucose Monitoring Systems Market: Competitive Landscape

The report provides profiles of the companies in the market such as Dexcom, Inc., Medtronic, Abbott, Integrity Applications, Nano Nordisk, OrSense, Bayer AG, Johnson & Johnson Services, Senseonics Holdings, and Others.

Reasons to Buy this Report:

- Comprehensive analysis of global as well as regional markets of the continuous blood glucose monitoring systems.

- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.

- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.

- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.